Publications by authors named "Jonathan Solberg"

Claim this Profile
L
Large-scale high-throughput screen for cardiac ryanodine receptor targeted therapeutics.
Roman Nikolaienko, Elisa Bovo, Jonathan C Solberg, Marzena Brinkmann, Levy M Treinen

J Biol Chem· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrocyclic dihydropyridine analogs as pan-BET BD2-preferred inhibitors.
Jiewei Jiang, Taimeng Liang, Jonathan Solberg, Alice Chan, Prakriti Kalra

Eur J Med Chem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the Selectivity of Protein-Protein and Small Molecule Interactions with Fluorinated Tandem Bromodomain Reader Proteins.
Prakriti Kalra, Logan McGraw, Jennifer R Kimbrough, Anil K Pandey, Jonathan Solberg

ACS Chem Biol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probing the S2' Subsite of the Anthrax Toxin Lethal Factor Using Novel N-Alkylated Hydroxamates.
Elbek K Kurbanov, Ting-Lan Chiu, Jonathan Solberg, Subhashree Francis, Kimberly M Maize

J Med Chem· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation.
Jayme L Dahlin, Rondedrick Sinville, Jonathan Solberg, Hui Zhou, Junhong Han

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.
Ming Li, Shivender M D Shandilya, Michael A Carpenter, Anurag Rathore, William L Brown, Jonathan Solberg

ACS Chem Biol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Academic emergency physicians' experiences with patient death.
Jared Strote, Erika Schroeder, John Lemos, Ryan Paganelli, Jonathan Solberg

Acad Emerg Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel non-hydroxamate anthrax toxin lethal factor inhibitors by topomeric searching, docking and scoring, and in vitro screening.
Ting-Lan Chiu, Jonathan Solberg, Satish Patil, Todd W Geders, Xia Zhang

J Chem Inf Model· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TLR-TLR cross talk in human PBMC resulting in synergistic and antagonistic regulation of type-1 and 2 interferons, IL-12 and TNF-alpha.
Tarun K Ghosh, Dan J Mickelson, Jonathan C Solberg, Kenneth E Lipson, Jon R Inglefield

Int Immunopharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Tarun K Ghosh, Dan J Mickelson, Jason Fink, Jonathan C Solberg, Jon R Inglefield

Cell Immunol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonist efficacy in MORS196L mutant is affected by the interaction between transmembrane domains of the opioid receptor.
Patricia A Claude-Geppert, Jiahui Liu, Jonathan Solberg, Laurie J Erickson-Herbrandson, Horace H Loh

J Pharmacol Exp Ther· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis